Illicit anabolic steroid use in athletes

Paul J. Perry, Kathleen H. Andersen, William R. Yates

The American Journal of Sports Medicine · 1990 · 110 citations · 24 references

Concepts

TL;DR

Recent anabolic steroid abuse scandals across all levels of sport prompted a study of 20 weight lifters' steroid use histories, noting that existing efficacy studies focus only on individual drugs. During 7‑ to 14‑week cycles, athletes typically combined two or three oral agents with two long‑acting injectable products. The 20 users consistently practiced polypharmacy, using oral doses similar to efficacy studies but injectable doses three to eight times higher, leading to significant weight and strength gains, mood disturbances, and highlighting the inadequacy of prior efficacy and toxicology studies to capture real‑world risks.

Abstract

Because of recent anabolic steroid abuse scandals at all levels of athletic competition ranging from high school sports to the 1988 Olympics in Seoul, Korea, the investigators closely examined the anabolic steroid use histories of 20 competitive and noncompetitive weight lifters. Steroid efficacy studies only examine the anabolic effects of individual drugs. However, these 20 steroid users consistently practiced polypharmacy. During steroid use cycles lasting between 7 and 14 weeks, athletes commonly used two or three oral agents and two long-acting injectable products. Dosages of oral preparations tended to be similar to those used in efficacy studies, whereas dosages of the long-acting injectable agents were approximately three to eight times greater than those used in controlled studies. Subjects reported significant increases in body weight and strength. In addition, mental status changes were reported that included symptoms of depression, hostility, aggression, and paranoia. Based on the pattern of anabolic steroid use currently being practiced in the United States, it is apparent that past efficacy and toxicology studies are of limited value in delineating the benefits and hazards of these drugs.

References

24